Humacyte Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$434.8M
Industry:Biotech
Founded:N/A
Lead Investor(s):Fresenius Medical Care
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Humacyte's estimated revenue is currently $20.2M per year.
  • Humacyte received $150.0M in venture funding in June 2018.
  • Humacyte's estimated revenue per employee is $144964
  • Humacyte's total funding is $434.8M.

Employee Data

  • Humacyte has 139 Employees.
  • Humacyte grew their employee count by 18% last year.
  • Humacyte currently has 15 job openings.

Executive Contacts

NameTitle
Juliana BlumCo-Founder/VP global regulatory affairs
Heather PrichardChief Operations Officer
Angela RoseSenior Director, Clinical Development
Roger DattiloExecutive Director, Supply Chain
Jack HarveyVP,, Commercial Manufacturing
Jeremy MainvilleAssociate Director QC Microbiology
Kimberly Slentz-KeslerDirector of Cell Research & Development
Pablo HernandezExecutive Director of Facilities and Site Engineering
Rob SchutteDirector of Process Development
Robert KirktonAssociate Director, New Product Development at Humacyte, Inc.

What Is Humacyte?

Biotechnology Company

keywords:Biotechnology,Healthcare,Pharmaceuticals

139

Number of Employees

$20.2M

Revenue (est)

15

Current Jobs

18%

Employee Growth %

$434.8M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Liquidia Techno...
$11.8M819%N/A
Asklepios BioPh...
$7.6M52136%N/A
Brii Bioscience...
$5.3M36112%N/A
Atox Bio
$6.2M4319%N/A
Milestone Pharm...
$6.4M4469%N/A
Dova Pharmaceut...
$10.4M140-8%N/A
Precision BioSc...
$23.6M16343%N/A
Humacyte
$20.2M13918%N/A
BioCryst Pharma...
$23.4M16234%N/A
G1 Therapeutics
$7.9M10830%N/A

Humacyte News

8-Apr-19 - Humacyte Awarded 'Large Project Prototype of the Year' from ...

DURHAM, N.C.--(BUSINESS WIRE)--Humacyte, an innovator in biotechnology and regenerative medicine, received the Medical Technology ...

27-Mar-19 - Science Translational Medicine Publishes Results That ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, an innovator in biotechnology and regenerative medicine, announced ...

1-Apr-19 - Bioengineering breakthrough: Durham firm's vessels, human ...

RESEARCH TRIANGLE PARK – Humacyte, a regenerative medicine company based in Durham, has demonstrated that its human acellular ...

Humacyte Funding

DateAmountRoundLead InvestorsReference
2014-01-22$37.3MUndisclosedArticle
2015-10-21$150.0MBMultipleArticle
2016-08-12$10.0MUndisclosedCalifornia Institute for Regenerative MedicineArticle
2017-10-05$18.0MUndisclosedArticle
2018-03-12$75.0MUndisclosedPointState CapitalArticle
2018-06-12$150.0MUndisclosedFresenius Medical CareArticle

Humacyte Executive Hires

DateNameTitleReference
2015-10-06Jeffrey H. LawsonChief Medical OfficerArticle
2018-06-20Jeffrey LawsonPresident and Chief Executive OfficeArticle
2018-10-08Douglas BlankenshipChief Financial OfficerArticle
2019-03-07Chris FangChief Medical OfficerArticle